Company Profiles

driven by the PitchBook Platform

Actinobac Biomed

Actinobac Biomed
2009 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
$4.4M LATEST DEAL AMOUNT
$5.5M TOTAL AMOUNT RAISED
Description

Developer of pharmaceutical technologies designed to target white blood cell diseases. The company's pharmaceutical technologies develop agents for the treatment of hematologic malignancies (leukemias & lymphomas), latent infections (HIV/AIDS & tuberculosis) and autoimmune diseases (rheumatoid arthritis, multiple sclerosis, Crohn's disease, type 1 diabetes, Lupus & psoriasis) based upon the natural biologic agent leukotoxin (Leukothera), which targets Leukocyte Function Antigen-1 (LFA-1) on white blood cells, providing medical institutes with Leukotoxin as a protein therapeutic for the treatment of hematologic malignancies.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
15 Pelham Road
Kendall Park, NJ 08824
United States

+1 (732) 371-2694
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Actinobac Biomed’s full profile, request a free trial.

Actinobac Biomed Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 12-Jul-2017 $4.4M $5.5M Completed Product Development
4. Grant 27-Oct-2014 00000 00.00 Completed Startup
3. Grant 28-Mar-2013 00000 00.00 Completed Startup
2. Early Stage VC 21-Feb-2013 $600k $1.1M Completed Startup
1. Seed Round 24-Mar-2009 $500k $500k Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Actinobac Biomed Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Foundation Venture Capital Group Venture Capital Minority 000 0000 000000 0
Kairos Ventures Venture Capital Minority 000 0000 000000 0
National Cancer Institute Government 000 0000 000000 0

You’re viewing 3 of 3 investors.

Actinobac Biomed Executive Team (2)

Name Title Board
Seat
Contact
Info
Benjamin Belinka Ph.D Co-Founder, President, Chief Executive Officer & Board Member
Scott Kachlany Ph.D Founder, Chief Scientific Officer & Board Member

You’re viewing 2 of 2 executives.

Actinobac Biomed Board Members (2)

Name Representing Role Since Contact
Info
Benjamin Belinka Ph.D Actinobac Biomed Co-Founder, President, Chief Executive Officer & Board Member 000 0000
Scott Kachlany Ph.D Actinobac Biomed Founder, Chief Scientific Officer & Board Member 000 0000

You’re viewing 2 of 2 board members.